BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9742648)

  • 1. [The treatment of infections in patients with neutropenia (a review of the literature with the inclusion of the authors' own data)].
    Ptushkin VV; Bagirova NS; Volkova MA
    Ter Arkh; 1998; 70(7):83-7. PubMed ID: 9742648
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient management of the febrile neutropenic child with cancer.
    Patrick CC; Shenep JL
    Adv Pediatr Infect Dis; 1999; 14():29-47. PubMed ID: 10079848
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of bacterial infections in acute leukemia.
    Bodey GP
    Leukemia; 1992; 6 Suppl 2():17-21. PubMed ID: 1578924
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on infections in neutropenic hosts.
    Gulick PG
    J Am Osteopath Assoc; 1990 Oct; 90(10):920-5. PubMed ID: 2279965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of G-CSF and GM-CSF in the adjunctive treatment of infections complicating chemotherapy of solid tumors in children. Report of Polish Pediatric Leukemia/Lymphoma Treatment Group].
    Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubała H; Drabko K; Eliasińska A; Kedziora M; Kołecki P; Kowalczyk J; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M
    Wiad Lek; 1998; 51 Suppl 4():65-71. PubMed ID: 10731946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myeloid growth factors can cure chronic neutropenia and facilitate cytostatic therapy].
    Palmblad J; Samuelsson J
    Lakartidningen; 1992 Mar; 89(13):1037-8, 1041. PubMed ID: 1372671
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.
    Yilmaz S; Oren H; Demircioğlu F; Irken G
    Pediatr Hematol Oncol; 2008; 25(3):195-204. PubMed ID: 18432502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune neutropenia: which therapy?].
    Salvini F; Farina F; Rettani GA; Bettiga C; Sala M
    Pediatr Med Chir; 2006; 28(4-6):106-8. PubMed ID: 17533906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infections in neutropenic patients].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antimicrobial therapy in neutropenia].
    Maschmeyer G; Vogt K; Hahn H; Dörken B
    Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.